Cookies © 2025 American Society of Clinical Oncology (ASCO). All Rights Reserved Worldwide.

Association between state Medicaid policies and accrual of Black and Hispanic patients to cancer clinical trials. - ASCO Home / Posters / Disclaimer ...

The Oncology Evaluation Center: Implementation of a same-day evaluation and treatment center to avoid unnecessary ED visits. - ASCO Home / Posters / Disclaimer ...

Randomized phase II study of S-1 monotherapy versus gemcitabine plus S-1 in gemcitabine-refractory advanced pancreatic cancer. - ASCO Home / Posters / Disclaimer ...

Efficacy and safety of encorafenib (enco) plus binimetinib (bini) in patients with <em>BRAF</em> V600E-mutant (<em>BRAF</em>^V600E) metastatic non-small ...

Initial experience with an innovative pilot program evaluating a multidisciplinary approach to supportive care planning in a survivorship clinic setting. - ASCO Home / Posters / Disclaimer ...

Anti-tumor activity, safety and pharmacokinetics (PK) of ASG-22CE (ASG-22ME; enfortumab vedotin) in a phase I dose escalation trial in patients (Pts) with metastatic urothelial cancer (mUC). - ASCO ...

Sign in to explore collection of abstracts, journal articles, posters, videos, and slides.

© 2025 American Society of Clinical Oncology (ASCO). All Rights Reserved Worldwide.

Sequential immunotherapy in rare variant renal cell carcinomafinal report of UNISoN (ANZUP 1602): Nivolumab then ipilimumab + nivolumab in advanced nonclear cell renal cell carcinoma. - ASCO Home / ...

Sign in to explore collection of abstracts, journal articles, posters, videos, and slides.

Sign in to explore collection of abstracts, journal articles, posters, videos, and slides.